-- 獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師的觀點總結如下：諾華2026年第一季業績低於市場預期，淨銷售額下降1%（以固定匯率計算下降5%），核心每股收益為1.99美元，低於市場預期的2.08美元。核心營業收入以固定匯率計算下降14%，利潤率下降4.1個百分點至37.3%，主要原因是仿製藥壓力加劇，尤其是Entresto的銷售額以固定匯率計算下降了46%。成長型產品Kisqali（以固定匯率計算成長55%）和Pluvicto（以固定匯率計算成長70%）在一定程度上抵銷了仿製藥帶來的不利影響。諾華重申了其2026年業績指引，預計銷售額按固定匯率計算將實現個位數低增長，核心營業收入按固定匯率計算將下降個位數低下降，並預計上半年將面臨挑戰，下半年將有所改善。預計2026年下半年將公佈多項3期臨床試驗結果，包括用於治療多發性硬化症的remibrutinib，這可能會增強其中長期成長前景。我們認為，儘管該公司在新產品方面擁有強勁的成長勢頭和廣泛的產品線，但Entresto是歐洲同行中近期專利風險最大的單一產品，這限制了其快速替代Entresto的可能性，即便其他產品有所增長。
Related Articles
Japan
GoldMining Announcing Updated PEA Highlighting US$1B After-Tax NPV and 32% IRR at La Mina Project, Colombia
$GOLD.TO
Australia
Armstrong World Industries Q1 Adjusted Earnings, Net Sales Rise; Raises 2026 Adjusted EPS Guidance
Armstrong World Industries (AWI) reported Q1 adjusted earnings Tuesday of $1.69 per diluted share, up from $1.66 a year earlier.Analysts polled by FactSet expected $1.81.Net sales for the quarter ended March 31 were $409.9 million, compared with $382.7 million a year earlier.Analysts surveyed by FactSet expected $409.5 million.For 2026, the company expects adjusted earnings of between $8.15 to $8.45 per diluted share, compared with its prior guidance of $8.05 to $8.35. Analysts polled by FactSet expect $8.30.Armstrong World Industries reiterated its full year net sales guidance of $1.75 billion to $1.79 billion. Analysts are looking for $1.77 billion.Shares of the company were down over 2% in Tuesday premarket activity.Price: $173.00, Change: $-4.75, Percent Change: -2.69%
$AWI
US Markets
Barclays Affirms 2026 Outlook Amid Higher Profit; New GBP500 Million Buyback Unveiled
Barclays (BARC.L) reiterated its financial targets for 2026 as it delivered a "solid" first-quarter performance despite logging higher impairment charges over the period.The British banking group's profit attributable to shareholders for the three months ended March 31 rose year over year to 1.93 billion pounds sterling from 1.86 billion pounds, according to a Tuesday earnings release. Before tax, profit reached 2.81 billion pounds, up from 2.72 billion pounds.Credit impairment charges widened to 823 million pounds from 643 million pounds, largely driven by a single name charge of 228 million pounds at the company's investment banking division. Bloomberg News reported Tuesday that the charge was linked to Market Financial Solutions, a UK-based specialized lender that collapsed in February."PBT was in line with consensus driven by better than expected revenues in the IB partially offset by a top-up for motor finance commissions (GBP105m), an impairment provision for MFS (GBP228m) and a cost miss in [Barclays UK]. On an underlying pre-provision profit basis, there was a 2% beat," analysts at RBC Capital Markets said in a quicktake note.Barclays also announced plans to launch a new 500 million-pound buyback once its current 1 billion-pound share repurchase program is completed.For full-year 2026, the group reaffirmed its goal to achieve a total income of 31 billion pounds and a return on tangible equity of more than 12%. Looking further ahead, Barclays also confirmed its 2028 targets, including a greater than 14% RoTE and plans to return more than 15 billion pounds of capital to shareholders over the 2026 to 2028 period through dividends and buybacks.As of Tuesday midday, the stock was trading nearly 1% lower in London.
$BARC.L